webmeister
- 02 Apr 2004 06:48
- 52 of 57
LW...Although Shell had probs estimating future reserves, 330 was an important low last year, climbing to 420 with very bullish divergence..Though the price has been edging lower RSI has made higher lows so descent could be slowing!!
Full year net profit was up on the back of higher prices @ $11.7 billion against $9.28 billion previously...
Current investment however, will not pay off until 2006/07.. Perhaps the worst is now over!?!
thestatusquo
- 13 Apr 2004 19:24
- 56 of 57
Not a high yield play, but in valuation terms Galen Holdings (GAL), has lost a bit of ground recently making it a STRONG BUY in my book. Whilst scares persist over HRT drugs, Galen's pipeline encompasses a much wider field, including oral contraceptives, acne treatments, analgesics, antibiotics and novel drug delivery systems. The HRT scares continue to be the reason Galen trades at a discount to the sector.
Excellent management, increased US sales force and earnings forecast to rise significantly over next 2 years to 66pence and 89pence. Pricing Galen on a p/e of 18( a slight discount to the sector average), gives me price targets of 1200pence for 04, and 1600pence for 05.
Present price ~820pence, IMHO STRONG BUY.
TSQ.
38
- 13 Apr 2004 22:50
- 57 of 57
Hi LW:
7 prospects filtered out of the 350 based on a good covered divi, positive EPS growth rates and postive trend ROCE - but with no regard to current news, sentiment or technicals: BATS / GLH / DXNS / JLT / MTN / DCG / BWNG
Not in a position to discuss them at the mo'...
Regards